Free Trial

Inhibrx (INBX) Short Interest Ratio & Short Volume

$34.35
+0.21 (+0.62%)
(As of 05/28/2024 ET)

Inhibrx Short Interest Data

Current Short Interest
2,050,000 shares
Previous Short Interest
2,190,000 shares
Change Vs. Previous Month
-6.39%
Dollar Volume Sold Short
$70.46 million
Short Interest Ratio
3.8 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
52,400,000 shares
Percentage of Shares Shorted
3.91%
Today's Trading Volume
1,872,442 shares
Average Trading Volume
607,915 shares
Today's Volume Vs. Average
308%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Inhibrx ?

Sign up to receive the latest short interest report for Inhibrx and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INBX Short Interest Over Time

INBX Days to Cover Over Time

INBX Percentage of Float Shorted Over Time

Inhibrx Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20242,050,000 shares $70.46 million -6.4%N/A3.8 $34.37
4/30/20242,190,000 shares $74.55 million -0.5%N/A4.7 $34.04
4/15/20242,200,000 shares $76.43 million +2.3%6.2%3.2 $34.74
3/31/20242,150,000 shares $75.16 million +34.4%6.0%3 $34.96
3/15/20241,600,000 shares $56 million -18.0%4.5%2.1 $35.00
2/29/20241,950,000 shares $71.43 million -7.1%5.5%2.6 $36.63
2/15/20242,100,000 shares $79.78 million -12.5%5.9%3 $37.99
1/31/20242,400,000 shares $92.47 million -41.3%6.7%3.4 $38.53
1/15/20244,090,000 shares $142.74 million +20.3%11.5%6.1 $34.90
12/31/20233,400,000 shares $129.20 million -6.1%9.6%7.4 $38.00
12/15/20233,620,000 shares $101.83 million -30.1%10.2%8.9 $28.13
11/30/20235,180,000 shares $107.59 million -2.1%15.0%12 $20.77
11/15/20235,290,000 shares $107.23 million +5.4%15.3%12 $20.27
10/31/20235,020,000 shares $77.66 million +1.0%15.0%11.2 $15.47
10/15/20234,970,000 shares $87.97 million -7.1%14.9%10.5 $17.70
9/30/20235,350,000 shares $98.17 million +11.2%16.0%11.9 $18.35
9/15/20234,810,000 shares $100.58 million -5.5%14.4%11.3 $20.91
8/31/20235,090,000 shares $108.93 million -12.8%15.3%12.8 $21.40
8/15/20235,840,000 shares $99.69 million +1.7%17.5%15.7 $17.07
7/31/20235,740,000 shares $115.09 million +0.9%18.0%16.4 $20.05
7/15/20235,690,000 shares $138.32 million -1.4%17.9%17 $24.31
6/30/20235,770,000 shares $149.79 million -4.0%18.2%16 $25.96
6/15/20236,010,000 shares $167.20 million +1.0%20.4%15.8 $27.82
5/31/20235,950,000 shares $140.78 million +3.3%20.2%15.4 $23.66
5/15/20235,760,000 shares $144.86 million +0.4%19.6%13.8 $25.15
4/30/20235,740,000 shares $120.54 million -2.1%19.5%14.1 $21.00
4/15/20235,860,000 shares $106.95 million -0.3%19.9%15.1 $18.25
3/31/20235,880,000 shares $110.96 million -3.0%20.0%14.5 $18.87
3/15/20236,060,000 shares $136.71 million +7.8%20.6%14.4 $22.56
2/28/20235,620,000 shares $135.22 million +8.5%19.1%12.9 $24.06
2/15/20235,180,000 shares $120.90 million -1.7%17.6%12.3 $23.34
1/31/20235,270,000 shares $131.75 million -3.0%19.1%11.7 $25.00
1/15/20235,430,000 shares $128.47 million +26.3%18.1%11.3 $23.66
12/30/20224,300,000 shares $105.95 million +8.6%14.4%8.5 $24.64
12/15/20223,960,000 shares $110.96 million -10.8%13.2%5.4 $28.02
11/30/20224,440,000 shares $133.11 million -1.1%15.7%5.7 $29.98
11/15/20224,490,000 shares $146.82 million -2.8%15.9%5.8 $32.70
10/31/20224,620,000 shares $148.67 million +16.7%18.0%6.2 $32.18
10/15/20223,960,000 shares $118.21 million -4.1%15.5%5.5 $29.85
9/30/20224,130,000 shares $74.13 million +25.5%16.2%5.9 $17.95
4 Cryptos BETTER than Bitcoin (Ad)

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024
9/15/20223,290,000 shares $48.66 million +0.6%12.9%6.9 $14.79
8/31/20223,270,000 shares $58.01 million +0.3%12.8%7.2 $17.74
8/15/20223,260,000 shares $80.46 million -13.3%12.8%7.5 $24.68
7/31/20223,760,000 shares $65.20 million +5.3%14.4%7.7 $17.34
7/15/20223,570,000 shares $61.69 million +15.2%13.7%7.2 $17.28
6/30/20223,100,000 shares $35.19 million -9.6%11.9%6.5 $11.35
6/15/20223,430,000 shares $30.73 million +4.6%13.2%8 $8.96
5/31/20223,280,000 shares $42.87 million +35.0%12.6%8.8 $13.07
5/15/20222,430,000 shares $41.16 million +12.0%9.4%7.2 $16.94
4/30/20222,170,000 shares $34.39 million +7.4%8.3%7.6 $15.85
4/15/20222,020,000 shares $37.01 million -10.2%7.7%7.1 $18.32
3/31/20222,250,000 shares $50.13 million +8.7%8.6%8 $22.28
3/15/20222,070,000 shares $41.77 million +0.5%7.9%7.4 $20.18
2/28/20222,060,000 shares $44.29 million -3.3%7.9%7 $21.50
2/15/20222,130,000 shares $51.87 million +13.3%8.2%7.5 $24.35
1/31/20221,880,000 shares $49.93 million +67.9%8.3%7.3 $26.56
1/15/20221,120,000 shares $35.26 million +4.7%N/A0 $31.48
12/31/20211,070,000 shares $46.73 million +56.0%4.7%4.5 $43.67
12/15/2021685,900 shares $27.83 million +5.6%3.0%2.9 $40.58
11/30/2021649,700 shares $26.27 million +1.3%2.9%3.3 $40.43
11/15/2021641,400 shares $28.54 million -25.2%2.8%3.4 $44.49
10/29/2021857,700 shares $34.47 million +4.1%3.8%4.6 $40.19
10/15/2021823,900 shares $32.72 million -3.8%3.7%4.7 $39.71
9/30/2021856,500 shares $28.53 million +17.6%3.8%6.5 $33.31
9/15/2021728,400 shares $26.37 million -10.0%3.2%4 $36.20
8/31/2021808,900 shares $23.07 million -20.7%3.6%4 $28.52
8/13/20211,020,000 shares $28.18 million -8.1%4.5%4.5 $27.63
7/30/20211,110,000 shares $31.59 million +0.9%4.9%5.1 $28.46
7/15/20211,100,000 shares $27.70 million -1.8%4.9%5.3 $25.18
6/30/20211,120,000 shares $30.82 million +35.0%5.0%5.3 $27.52
6/15/2021829,900 shares $21.54 million +6.5%3.7%5.2 $25.95
5/28/2021779,100 shares $16.49 million +1.3%3.5%6.4 $21.16
5/14/2021768,900 shares $12.93 million -8.2%3.4%6.6 $16.82
4/30/2021837,100 shares $16.43 million +5.1%3.7%5.3 $19.63
4/15/2021796,400 shares $16.58 million +52.1%3.6%5.3 $20.82
3/31/2021523,600 shares $8.86 million -21.7%2.3%3.6 $16.93
3/15/2021668,400 shares $15.71 million +19.6%3.0%3.9 $23.51
2/26/2021558,800 shares $14.98 million -8.2%2.5%3.3 $26.80
2/12/2021608,900 shares $22.53 million +4.3%2.7%3.9 $37.00
1/29/2021583,800 shares $19.08 million -16.8%2.6%5.7 $32.68
1/15/2021701,600 shares $25.26 million No Change3.2%6.6 $36.00

INBX Short Interest - Frequently Asked Questions

What is Inhibrx's current short interest?

Short interest is the volume of Inhibrx shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 2,050,000 shares of INBX short. Learn More on Inhibrx's current short interest.

What is a good short interest ratio for Inhibrx?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INBX shares currently have a short interest ratio of 4.0. Learn More on Inhibrx's short interest ratio.

Which institutional investors are shorting Inhibrx?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Inhibrx: Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Inhibrx's short interest increasing or decreasing?

Inhibrx saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 2,050,000 shares, a drop of 6.4% from the previous total of 2,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Inhibrx's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Inhibrx: Fusion Pharmaceuticals Inc. (3.60%), Sana Biotechnology, Inc. (21.23%), Ginkgo Bioworks Holdings, Inc. (19.74%), Beam Therapeutics Inc. (17.71%), Neumora Therapeutics, Inc. (11.63%), Novavax, Inc. (32.26%), Tarsus Pharmaceuticals, Inc. (19.77%), Kymera Therapeutics, Inc. (16.09%), ADMA Biologics, Inc. (3.64%), Vir Biotechnology, Inc. (6.99%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Inhibrx stock?

Short selling INBX is an investing strategy that aims to generate trading profit from Inhibrx as its price is falling. INBX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Inhibrx?

A short squeeze for Inhibrx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBX, which in turn drives the price of the stock up even further.

How often is Inhibrx's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:INBX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners